Verastem (VSTM) Shares Outstanding (Diluted Average) (2016 - 2025)

Verastem (VSTM) recorded quarterly Shares Outstanding (Diluted Average) of $69.3 million in Q4 2025, up 7.35% quarter-over-quarter from $64.6 million in Q3 2025, and up 94.07% on a YoY basis from $35.7 million in Q4 2024.

Verastem (VSTM) Shares Outstanding (Diluted Average) (2016 - 2025) Analysis & Trends

Verastem's Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $69.3 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Diluted Average) rose 94.07% year-over-year to $69.3 million; the TTM figure through Dec 2025 stood at $69.3 million (up 94.07% YoY), while the FY2025 annual figure was $69.3 million, up 94.07% from the prior year.
  • Shares Outstanding (Diluted Average) was $69.3 million for Q4 2025 at Verastem, up from $64.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $200.7 million in Q1 2023 to a low of $14.5 million in Q4 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $96.6 million across 5 years, with a median of $64.6 million in 2025.
  • The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Diluted Average) soared 9379.55% in 2021, then plunged 89.24% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $14.5 million in 2021, then advanced by 11.03% to $16.1 million in 2022, then surged by 36.66% to $22.1 million in 2023, then surged by 61.93% to $35.7 million in 2024, then soared by 94.07% to $69.3 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $69.3 million (Q4 2025), $64.6 million (Q3 2025), and $54.2 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 69.31 Mn
Sep 30, 2025 64.56 Mn
Mar 31, 2025 54.17 Mn
Dec 31, 2024 35.71 Mn
Sep 30, 2024 31.35 Mn
Mar 31, 2024 26.83 Mn
Dec 31, 2023 22.05 Mn
Sep 30, 2023 20.45 Mn
Mar 31, 2023 200.68 Mn
Dec 31, 2022 16.14 Mn
Sep 30, 2022 190.00 Mn
Jun 30, 2022 186.36 Mn
Mar 31, 2022 186.26 Mn
Dec 31, 2021 14.54 Mn
Sep 30, 2021 179.86 Mn
Jun 30, 2021 171.99 Mn
Mar 31, 2021 171.59 Mn
Dec 31, 2020 153,330.00
Sep 30, 2020 147.77 Mn
Dec 31, 2019 74.58 Mn